Pfizer moves to dismiss US states' amended generic drug price-fixing claims
MLex Summary: Pfizer moved to dismiss state plaintiffs’ amended US price-fixing claims over generic drugs, saying it cannot be held liable for the conduct of former subsidiary Greenstone LLC.See attached file. ...To view the full article, register now.
Already a subscriber? Click here to view full article